Navigation Links
Phalanx Biotech Group Launches microRNA Microarray - miRBase v17
Date:8/24/2011

BELMONT, Calif., Aug. 24, 2011 /PRNewswire/ -- Phalanx Biotech Group, a global provider of genomic products and services, launches a major update to its OneArray® microRNA expression profiling microarrays based on the latest miRBase release – Version 17.  This miRBase release represents a significant increase over Version 16 in the number of microRNA sequences with 2,406 additional mature microRNA - of which 563 represent newly verified sequences in human, mouse and rats.  Researchers using OneArray® microRNA products will benefit from more comprehensive interrogation power of validated microRNA transcripts as opposed to those using Affymetrix, Agilent or Exiqon microarrays based on older miRBase versions. The OneArray® microRNA line includes human, mouse, rat and seven major plant species - rice, corn, soybean, grapevine, Sorghum, Arabidopsis, and Brachypodium.  

"At Phalanx Biotech, we continuously strive to make improvements in probe coverage, performance, and usability for all of our OneArray microarray products. This latest microRNA product release marks the third update to our microRNA product line, and features not only the most current annotation, but also a new hybridization chemistry enabling greater microarray signal intensities at reduced sample input," said Richard Su, Head of Product Development. "Furthermore, as our whole genome gene expression microarray product line expands, we anticipate a set of complementary microRNA microarrays to offer researchers the capability to conduct gene and microRNA expression profiling studies in parallel."

About microRNA

MicroRNA or miRNA are short ribonucleic acid molecules (approximately 22 nucleotides long) that often play roles in regulating the expression of genes, usually by binding to target messenger RNA (mRNA) sequences and impeding their function through mRNA degradation or blocking the translation of mRNA.  Researchers are focusing their efforts in uncovering the regulatory circuitry afforded by microRNA – investigating the role of microRNA in processes as diverse as embryonic development, cell proliferation, differentiation, and apoptosis.  Comparative microRNA expression profiling studies among different cell populations and tissue types demonstrate increasing correlations between microRNA and disease.  The combination of gene expression and microRNA profiles will enhance our understanding of biological mechanisms and the genes associated in these processes.  

About Phalanx Biotech Group

Phalanx Biotech Group, with operations in California and Taiwan, provides genomics research products and services worldwide to academic, pharmaceutical and biotech communities. Built on world-class, integrated-chip foundry technology, Phalanx Biotech has developed the OneArray® line of high-quality and affordable microarrays for expression profiling of whole genomes, microRNA, and custom targets.  Our highly-trained service specialists provide a comprehensive offering of gene expression and microRNA profiling services for biomarker discovery including sample preparation, expression analysis, and qPCR validation. For more information about our products and services, please visit our website at www.phalanxbiotech.com.

Contact
Kevin Poon, 1-650-320-8669 ext 111
kevinpoon@onearray.com


'/>"/>
SOURCE Phalanx Biotech Group
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Spaulding Clinical Announces Strategic Partnership with Clinigene International, India for Providing Comprehensive Early Clinical Solutions to Pharmaceutical and Biotech Clients
2. VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
3. IU Confidential Publishes Biotech Investment Report
4. Australian Biotech Ceridia Pty Ltd Completes Successful Human Clinical Trial
5. Top 5 Ways to Get Insider Track on Healthcare, Pharma & Biotech Discoveries & Latest News
6. Aeras and China National Biotech Group Sign Memorandum of Understanding for TB Vaccine R&D Collaboration
7. 2011 Prix Galien USA Final Candidates Announced: Competing for Best Biotechnology Product and Best Pharmaceutical Agent
8. Lilly Announces New Investment to Further Boost Its Biotechnology Capabilities
9. Goodwin Biotechnology Announces a Collaboration With Alethia Biotherapeutics
10. TriLink BioTechnologies, Inc. Awarded European Patent for CleanAmp™ Primers
11. Olympus Biotech Names Oliver Burckhardt to President North America
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals ... innovative therapeutics that address significant unmet medical needs, ... from the Company,s consumer product development program, based ... the Society for Investigative Dermatology (SID) 76 th ... advance and promote the sciences relevant to skin ...
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology:
(Date:4/28/2017)... , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... name the Creator responds to and which He does not. Yisrayl says with so ... one is the true name, but he says with a little Scripture, backed with a ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA ... region. Côté has 20+ years of experience within the beauty industry, ranging from ... an array of high-end cosmetic brands, retail brands and outlets in Canada and ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation ... supplements, through its Nova Skin Sciences division, recently announced the launch of Allumière ... with the power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark ...
(Date:4/28/2017)... ... ... Rob Lowe is a popular actor that has been in many different movies ... as the host of the “Informed” series. The program focuses on many important issues ... focuses on thyroid cancer. , Although thyroid cancer is an uncommon type of cancer, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Christie Medical Holdings, Inc. ... alliance with B. Braun Medical Inc. , a leader in infusion therapy and ... with as many as 90 percent of hospital patients receiving a peripheral IV catheter ...
Breaking Medicine News(10 mins):